- Senate passes Drug Quality and Security Act
- ROUNDTABLE: Pharmacy’s future in sync with technology
- Coalition of healthcare industry stakeholders address best practices regarding controlled substances
- Reports: Bill to extend federal regulations for compounding pharmacies expected to pass House, Senate
- Study from NCPA sheds new light on med synchronization programs
NEW YORK — The executive director of the Oregon Board of Pharmacy is leaving, according to published reports.
The Lund Report, an online publication that covers Oregon's healthcare system, reported that Gary Schnabel was stepping down to pursue "other interests." Schnabel turned 65 years old this month and has lead the board for 19 years.
Highlights from Schnabel's career include being invited by former Sen. Gordon Smith, R-Ore., in January 2005 to testify before Congress on the state's experience with selling drugs online, just before the confirmation of then-Secretary of State Condoleezza Rice.
According to The Lund Report, Schnabel intends to work as a consultant, doing on-site inspections of compounding pharmacies for the National Association of Boards of Pharmacy and consulting with drug companies.